Computational Genomics & Transcriptomics Laboratory

Rahul Kumar completed his PhD in Bioinformatics from CSIR-IMTECH, Chandigarh. In his PhD, he worked on developing biological databases and machine learning based prediction models to design anticancer therapeutics. Then, he joined Institute of Cancer Research, London and there he worked on identification of synthetic lethal interactions using high throughput genomic technologies. Then he joined Memorial Sloan Kettering Cancer Center, New York and extensively worked on genetics of rare form of breast cancers to identify their putative genetic drivers. Later he joined Columbia University Irving Medical Center, New York as a staff scientist and focused on non-coding genome of diffuse large B-cell lymphoma (DLBCL), an aggressive type of blood cancer.